首页> 美国卫生研究院文献>Antioxidants >Flavonoids-Macromolecules Interactions in Human Diseases with Focus on Alzheimer Atherosclerosis and Cancer
【2h】

Flavonoids-Macromolecules Interactions in Human Diseases with Focus on Alzheimer Atherosclerosis and Cancer

机译:黄酮类 - 大分子在人类疾病中的相互作用重点关注阿尔茨海默动脉粥样硬化和癌症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Flavonoids, a class of polyphenols, consumed daily in our diet, are associated with a reduced risk for oxidative stress (OS)-related chronic diseases, such as cardiovascular disease, neurodegenerative diseases, cancer, and inflammation. The involvement of flavonoids with OS-related chronic diseases have been traditionally attributed to their antioxidant activity. However, evidence from recent studies indicate that flavonoids’ beneficial impact may be assigned to their interaction with cellular macromolecules, rather than exerting a direct antioxidant effect. This review provides an overview of the recent evolving research on interactions between the flavonoids and lipoproteins, proteins, chromatin, DNA, and cell-signaling molecules that are involved in the OS-related chronic diseases; it focuses on the mechanisms by which flavonoids attenuate the development of the aforementioned chronic diseases via direct and indirect effects on gene expression and cellular functions. The current review summarizes data from the literature and from our recent research and then compares specific flavonoids’ interactions with their targets, focusing on flavonoid structure–activity relationships. In addition, the various methods of evaluating flavonoid–protein and flavonoid–DNA interactions are presented. Our aim is to shed light on flavonoids action in the body, beyond their well-established, direct antioxidant activity, and to provide insights into the mechanisms by which these small molecules, consumed daily, influence cellular functions.
机译:黄酮类化合物,一类每天在我们饮食中消耗的多酚,与氧化应激(OS)的风险降低有关,例如心血管疾病,神经变性疾病,癌症和炎症。黄酮类化合物与OS相关的慢性疾病的参与传统上归因于其抗氧化活性。然而,来自最近研究的证据表明,可以将黄酮类化合物的有益影响分配给它们与细胞大分子的相互作用,而不是发挥直接抗氧化效应。本综述概述了最近的一种不断发展的对来自OS相关的慢性疾病所涉及的类化合物和脂蛋白,蛋白质,染色质,DNA和涉及的细胞信号传导分子之间的相互作用研究;它专注于黄酮类化合物通过直接和间接影响对基因表达和细胞功能的影响衰减上述慢性疾病的发展。目前的审查总结了文献中的数据以及我们最近的研究,然后将特定的黄酮类化合物与其目标的相互作用进行了比较,重点是黄酮类结构 - 活动关系。此外,介绍了评估黄酮类化蛋白和黄酮类化合物相互作用的各种方法。我们的宗旨是在身体上的黄酮类药物上脱光,超出其完善,直接的抗氧化剂活动,并向每日消耗的机制提供洞察力,每天消耗,影响细胞功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号